NCT06255145

Brief Summary

The goal of this randomized controlled trial is to evaluate body composition, fatigue, mobility level, functional status in with stroke individuals. The main questions it aims to answer are: How is body composition affected in individuals with stroke? How is the level of fatigue affected in individuals with stroke? How is the mobility level affected in individuals with stroke? How is functional status affected in individuals with stroke? In this study, we included 21 patients with stroke and 21 healthy controls. The body composition of the participants was evaluated by Bioelectrical Impedance Analysis (BIA), fatigue level by Fatigue Severity Scale (FSS), mobility level by Rivermead Mobility Index (RMI), and functional status by Functional Independence Scale (FIM).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 17, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 5, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 5, 2022

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

October 14, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

February 13, 2024

Completed
Last Updated

February 13, 2024

Status Verified

February 1, 2024

Enrollment Period

6 months

First QC Date

October 14, 2023

Last Update Submit

February 2, 2024

Conditions

Keywords

StrokeBody CompositionFatiqueMobilityFunctional Status

Outcome Measures

Primary Outcomes (6)

  • Bioelectrical Impedance Analysis

    body weight

    12 week

  • Bioelectrical Impedance Analysis

    body fat percentage

    12 week

  • Bioelectrical Impedance Analysis

    muscle percentage

    12 week

  • Bioelectrical Impedance Analysis

    total water percentage

    12 week

  • Bioelectrical Impedance Analysis

    visceral fat amount

    12 week

  • Bioelectrical Impedance Analysis

    total bone mass

    12 week

Secondary Outcomes (3)

  • Fatigue Severity Scale

    12 week

  • Rivermead Mobility Index

    12 week

  • Functional Independence Scale

    12 week

Study Arms (2)

Experimental group

EXPERIMENTAL

In all participants, body composition evaluation was carried out with the Beurer BF 1000 Super Precision device using the Bioelectrical Impedance Analysis principle, fatigue evaluation was carried out with the Fatigue Severity Scale, mobility evaluation was carried out with the Rivermead Mobility Index, and functional status evaluation was carried out with the Functional Independence Scale.

Device: Bioelectrical Impedance Analysis

Control Group

ACTIVE COMPARATOR

In all participants, body composition evaluation was carried out with the Beurer BF 1000 Super Precision device using the Bioelectrical Impedance Analysis principle, fatigue evaluation was carried out with the Fatigue Severity Scale, mobility evaluation was carried out with the Rivermead Mobility Index, and functional status evaluation was carried out with the Functional Independence Scale.

Device: Bioelectrical Impedance Analysis

Interventions

Bioelectrical Impedance Analysis Beurer BF 1000 Super Precision device was used to measure the body composition of the participants. Operating on the principle of BIA, the device allows the body composition to be evaluated by giving an imperceptible electric current to the body. Fatigue Severity Scale (FSS) Fatigue Severity Scale (FSS) was used to measure participants' fatigue levels. Rivermead Mobility Index Rivermead Mobility Index (RMI) was used to assess the mobility levels of the participants. Functional Independence Measure Functional Independence Measure (FIM) was used to evaluate the functional status of the participants.

Also known as: Fatigue Severity Scale, Rivermead Mobility Index, Functional Independence Scale
Control GroupExperimental group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being between the ages of 18-65
  • Volunteering to participate in the study
  • Having a score of 25 or above on the Mini Mental Test
  • Getting a score between 0-3 on the Modified Rankin Scale

You may not qualify if:

  • Having cardiac insufficiency
  • Being morbid obesity
  • Having pacemaker
  • Being pregnant
  • Being between the ages of 30-65
  • Volunteering to participate in the study
  • Not having any neurological, orthopedic, rheumatologic and metabolic problems
  • Having a score of 25 or above on the Mini Mental Test
  • Participating in any fat burning diet program
  • Exercising regularly
  • Being pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pamukkale University

Denizli, 20160, Turkey (Türkiye)

Location

Related Publications (33)

  • Sudlow CL, Warlow CP. Comparing stroke incidence worldwide: what makes studies comparable? Stroke. 1996 Mar;27(3):550-8. doi: 10.1161/01.str.27.3.550.

    PMID: 8610328BACKGROUND
  • Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, Kamel H, Kernan WN, Kittner SJ, Leira EC, Lennon O, Meschia JF, Nguyen TN, Pollak PM, Santangeli P, Sharrief AZ, Smith SC Jr, Turan TN, Williams LS. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021 Jul;52(7):e364-e467. doi: 10.1161/STR.0000000000000375. Epub 2021 May 24. No abstract available.

    PMID: 34024117BACKGROUND
  • Siotto M, Germanotta M, Guerrini A, Pascali S, Cipollini V, Cortellini L, Ruco E, Khazrai YM, De Gara L, Aprile I. Relationship between Nutritional Status, Food Consumption and Sarcopenia in Post-Stroke Rehabilitation: Preliminary Data. Nutrients. 2022 Nov 15;14(22):4825. doi: 10.3390/nu14224825.

    PMID: 36432512BACKGROUND
  • Purroy F, Montala N. Epidemiology of stroke in the last decade: a systematic review. Rev Neurol. 2021 Nov 1;73(9):321-336. doi: 10.33588/rn.7309.2021138. English, Spanish.

    PMID: 34676530BACKGROUND
  • Scherbakov N, von Haehling S, Anker SD, Dirnagl U, Doehner W. Stroke induced Sarcopenia: muscle wasting and disability after stroke. Int J Cardiol. 2013 Dec 10;170(2):89-94. doi: 10.1016/j.ijcard.2013.10.031. Epub 2013 Oct 14.

    PMID: 24231058BACKGROUND
  • Li S, Gonzalez-Buonomo J, Ghuman J, Huang X, Malik A, Yozbatiran N, Magat E, Francisco GE, Wu H, Frontera WR. Aging after stroke: how to define post-stroke sarcopenia and what are its risk factors? Eur J Phys Rehabil Med. 2022 Oct;58(5):683-692. doi: 10.23736/S1973-9087.22.07514-1. Epub 2022 Sep 5.

    PMID: 36062331BACKGROUND
  • Su Y, Asamoto M, Yuki M, Saito M, Hasebe N, Hirayama K, Otsuki M, Iino C. Predictors and short-term outcomes of post-stroke fatigue in initial phase of transition from hospital to home: A prospective observational study. J Adv Nurs. 2021 Apr;77(4):1825-1838. doi: 10.1111/jan.14731. Epub 2020 Dec 23.

    PMID: 33368578BACKGROUND
  • Paciaroni M, Acciarresi M. Poststroke Fatigue. Stroke. 2019 Jul;50(7):1927-1933. doi: 10.1161/STROKEAHA.119.023552. Epub 2019 Jun 14. No abstract available.

    PMID: 31195940BACKGROUND
  • Mayo NE, Wood-Dauphinee S, Cote R, Durcan L, Carlton J. Activity, participation, and quality of life 6 months poststroke. Arch Phys Med Rehabil. 2002 Aug;83(8):1035-42. doi: 10.1053/apmr.2002.33984.

    PMID: 12161823BACKGROUND
  • Tani Y, Otaka Y, Kudo M, Kurayama T, Kondo K. Prevalence of Genu Recurvatum during Walking and Associated Knee Pain in Chronic Hemiplegic Stroke Patients: A Preliminary Survey. J Stroke Cerebrovasc Dis. 2016 May;25(5):1153-1157. doi: 10.1016/j.jstrokecerebrovasdis.2016.01.028. Epub 2016 Feb 19.

    PMID: 26907679BACKGROUND
  • Mally K, Trentmann J, Heller M, Dittmar M. Reliability and accuracy of segmental bioelectrical impedance analysis for assessing muscle and fat mass in older Europeans: a comparison with dual-energy X-ray absorptiometry. Eur J Appl Physiol. 2011 Aug;111(8):1879-87. doi: 10.1007/s00421-010-1795-x. Epub 2011 Jan 14.

    PMID: 21234595BACKGROUND
  • Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989 Oct;46(10):1121-3. doi: 10.1001/archneur.1989.00520460115022.

    PMID: 2803071BACKGROUND
  • Ozyemisci-Taskiran O, Batur EB, Yuksel S, Cengiz M, Karatas GK. Validity and reliability of fatigue severity scale in stroke. Top Stroke Rehabil. 2019 Mar;26(2):122-127. doi: 10.1080/10749357.2018.1550957. Epub 2018 Nov 26.

    PMID: 30475156BACKGROUND
  • Collen FM, Wade DT, Robb GF, Bradshaw CM. The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment. Int Disabil Stud. 1991 Apr-Jun;13(2):50-4. doi: 10.3109/03790799109166684.

    PMID: 1836787BACKGROUND
  • Ottenbacher KJ, Hsu Y, Granger CV, Fiedler RC. The reliability of the functional independence measure: a quantitative review. Arch Phys Med Rehabil. 1996 Dec;77(12):1226-32. doi: 10.1016/s0003-9993(96)90184-7.

    PMID: 8976303BACKGROUND
  • Chang KV, Wu WT, Huang KC, Han DS. Segmental body composition transitions in stroke patients: Trunks are different from extremities and strokes are as important as hemiparesis. Clin Nutr. 2020 Jun;39(6):1968-1973. doi: 10.1016/j.clnu.2019.08.024. Epub 2019 Aug 31.

    PMID: 31522786BACKGROUND
  • Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019 Jun 29;393(10191):2636-2646. doi: 10.1016/S0140-6736(19)31138-9. Epub 2019 Jun 3.

    PMID: 31171417BACKGROUND
  • Ramsay JW, Barrance PJ, Buchanan TS, Higginson JS. Paretic muscle atrophy and non-contractile tissue content in individual muscles of the post-stroke lower extremity. J Biomech. 2011 Nov 10;44(16):2741-6. doi: 10.1016/j.jbiomech.2011.09.001. Epub 2011 Sep 25.

    PMID: 21945568BACKGROUND
  • Borschmann K, Iuliano S, Ghasem-Zadeh A, Churilov L, Pang MYC, Bernhardt J. Upright activity and higher motor function may preserve bone mineral density within 6 months of stroke: a longitudinal study. Arch Osteoporos. 2018 Jan 8;13(1):5. doi: 10.1007/s11657-017-0414-4.

    PMID: 29313169BACKGROUND
  • Aali G, Drummond A, das Nair R, Shokraneh F. Post-stroke fatigue: a scoping review. F1000Res. 2020 Apr 7;9:242. doi: 10.12688/f1000research.22880.2. eCollection 2020.

    PMID: 32934800BACKGROUND
  • Choi-Kwon S, Choi SH, Suh M, Choi S, Cho KH, Nah HW, Song H, Kim JS. Musculoskeletal and central pain at 1 year post-stroke: associated factors and impact on quality of life. Acta Neurol Scand. 2017 Apr;135(4):419-425. doi: 10.1111/ane.12617. Epub 2016 Jun 6.

    PMID: 27265610BACKGROUND
  • MacIntosh BJ, Edwards JD, Kang M, Cogo-Moreira H, Chen JL, Mochizuki G, Herrmann N, Swardfager W. Post-stroke Fatigue and Depressive Symptoms Are Differentially Related to Mobility and Cognitive Performance. Front Aging Neurosci. 2017 Oct 31;9:343. doi: 10.3389/fnagi.2017.00343. eCollection 2017.

    PMID: 29163127BACKGROUND
  • Bye A, Sjoblom B, Wentzel-Larsen T, Gronberg BH, Baracos VE, Hjermstad MJ, Aass N, Bremnes RM, Flotten O, Jordhoy M. Muscle mass and association to quality of life in non-small cell lung cancer patients. J Cachexia Sarcopenia Muscle. 2017 Oct;8(5):759-767. doi: 10.1002/jcsm.12206. Epub 2017 May 10.

    PMID: 28493418BACKGROUND
  • Wang B, Thapa S, Zhou T, Liu H, Li L, Peng G, Yu S. Cancer-related fatigue and biochemical parameters among cancer patients with different stages of sarcopenia. Support Care Cancer. 2020 Feb;28(2):581-588. doi: 10.1007/s00520-019-04717-0. Epub 2019 May 17.

    PMID: 31102055BACKGROUND
  • al-Majid S, McCarthy DO. Cancer-induced fatigue and skeletal muscle wasting: the role of exercise. Biol Res Nurs. 2001 Jan;2(3):186-97. doi: 10.1177/109980040100200304.

    PMID: 11547540BACKGROUND
  • Morgado PC, Giorlando A, Castro M, Navigante A. Relationship between weight loss and parameters of skeletal muscle function in patients with advanced cancer and fatigue. Support Care Cancer. 2016 Sep;24(9):3961-6. doi: 10.1007/s00520-016-3236-9. Epub 2016 Apr 28.

    PMID: 27126771BACKGROUND
  • Neefjes ECW, van den Hurk RM, Blauwhoff-Buskermolen S, van der Vorst MJDL, Becker-Commissaris A, de van der Schueren MAE, Buffart LM, Verheul HMW. Muscle mass as a target to reduce fatigue in patients with advanced cancer. J Cachexia Sarcopenia Muscle. 2017 Aug;8(4):623-629. doi: 10.1002/jcsm.12199. Epub 2017 Jun 21.

    PMID: 28639432BACKGROUND
  • Wagner LI, Cella D. Fatigue and cancer: causes, prevalence and treatment approaches. Br J Cancer. 2004 Aug 31;91(5):822-8. doi: 10.1038/sj.bjc.6602012.

    PMID: 15238987BACKGROUND
  • Neefjes EC, van der Vorst MJ, Blauwhoff-Buskermolen S, Verheul HM. Aiming for a better understanding and management of cancer-related fatigue. Oncologist. 2013;18(10):1135-43. doi: 10.1634/theoncologist.2013-0076. Epub 2013 Sep 13.

    PMID: 24037979BACKGROUND
  • Peters DM, O'Brien ES, Kamrud KE, Roberts SM, Rooney TA, Thibodeau KP, Balakrishnan S, Gell N, Mohapatra S. Utilization of wearable technology to assess gait and mobility post-stroke: a systematic review. J Neuroeng Rehabil. 2021 Apr 21;18(1):67. doi: 10.1186/s12984-021-00863-x.

    PMID: 33882948BACKGROUND
  • Ursin MH, Ihle-Hansen H, Fure B, Tveit A, Bergland A. Effects of premorbid physical activity on stroke severity and post-stroke functioning. J Rehabil Med. 2015 Aug 18;47(7):612-7. doi: 10.2340/16501977-1972.

    PMID: 26073856BACKGROUND
  • Hebert D, Lindsay MP, McIntyre A, Kirton A, Rumney PG, Bagg S, Bayley M, Dowlatshahi D, Dukelow S, Garnhum M, Glasser E, Halabi ML, Kang E, MacKay-Lyons M, Martino R, Rochette A, Rowe S, Salbach N, Semenko B, Stack B, Swinton L, Weber V, Mayer M, Verrilli S, DeVeber G, Andersen J, Barlow K, Cassidy C, Dilenge ME, Fehlings D, Hung R, Iruthayarajah J, Lenz L, Majnemer A, Purtzki J, Rafay M, Sonnenberg LK, Townley A, Janzen S, Foley N, Teasell R. Canadian stroke best practice recommendations: Stroke rehabilitation practice guidelines, update 2015. Int J Stroke. 2016 Jun;11(4):459-84. doi: 10.1177/1747493016643553. Epub 2016 Apr 14.

    PMID: 27079654BACKGROUND
  • Silva CRRD, Pimenta CJL, Viana LRC, Ferreira GRS, Bezerra TA, Costa TFD, Pontes MLF, Costa KNFM. Specific health-related quality of life in Cerebrovascular accident survivors: associated factors. Rev Bras Enferm. 2021 Nov 29;75(3):e20210407. doi: 10.1590/0034-7167-2021-0407. eCollection 2021. English, Portuguese.

    PMID: 34852127BACKGROUND

Related Links

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Raziye Çelik, PT.

    Pamukkale University

    PRINCIPAL INVESTIGATOR
  • Emre Baskan, Assoc Prof.

    Pamukkale University

    STUDY DIRECTOR
  • Aziz Dengiz, PT Phd

    Muş Alparslan University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
FACTORIAL
Model Details: Based on the results of the power analysis, it was calculated that 80% power could be obtained at 95% confidence level when at least 42 people (21 people for each group) were included in the study all participants, body composition evaluation was carried out with the Beurer BF 1000 Super Precision device using the Bioelectrical Impedance Analysis principle, fatigue evaluation was carried out with the Fatigue Severity Scale, mobility evaluation was carried out with the Rivermead Mobility Index, and functional status evaluation was carried out with the Functional Independence Scale.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator physiotherapist

Study Record Dates

First Submitted

October 14, 2023

First Posted

February 13, 2024

Study Start

December 17, 2021

Primary Completion

June 5, 2022

Study Completion

July 5, 2022

Last Updated

February 13, 2024

Record last verified: 2024-02

Locations